Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation. (2nd June 2020)
- Record Type:
- Journal Article
- Title:
- Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation. (2nd June 2020)
- Main Title:
- Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation
- Authors:
- Petragnano, Francesco
Pietrantoni, Ilaria
Di Nisio, Valentina
Fasciani, Irene
Del Fattore, Andrea
Capalbo, Carlo
Cheleschi, Sara
Tini, Paolo
Orelli, Simone
Codenotti, Silvia
Mazzei, Maria Antonietta
D'Ermo, Giuseppe
Pannitteri, Gaetano
Tombolini, Mario
De Cesaris, Paola
Riccioli, Anna
Filippini, Antonio
Milazzo, Luisa
Vulcano, Francesca
Fanzani, Alessandro
Maggio, Roberto
Marampon, Francesco
Tombolini, Vincenzo - Abstract:
- Abstract: Purpose: Radiation therapy (RT), by using ionizing radiation (IR), destroys cancer cells inducing DNA damage. Despite several studies are continuously performed to identify the best curative dose of IR, the role of dose-rate, IR delivered per unit of time, on tumor control is still largely unknown. Materials and methods: Rhabdomyosarcoma (RMS) and prostate cancer (PCa) cell lines were irradiated with 2 or 10 Gy delivered at dose-rates of 1.5, 2.5, 5.5 and 10.1 Gy/min. Cell-survival rate and cell cycle distribution were evaluated by clonogenic assays and flow cytometry, respectively. The production of reactive oxygen species (ROS) was detected by cytometry. Quantitative polymerase chain reaction assessed the expression of anti-oxidant-related factors including NRF2, SODs, CAT and GPx4 and miRNAs (miR-22, -126, -210, -375, -146a, -34a). Annexin V and caspase-8, -9 and -3 activity were assessed to characterize cell death. Senescence was determined by assessing β-galactosidase (SA-β-gal) activity. Immunoblotting was performed to assess the expression/activation of: i) phosphorylated H2AX (γ-H2AX), markers of DNA double strand breaks (DSBs); ii) p19 Kip1/Cip1, p21 Waf1/Cip1 and p27 Kip1/Cip1, senescence-related-markers; iii) p62, LC3-I and LC3-II, regulators of autophagy; iv) ATM, RAD51, DNA-PKcs, Ku70 and Ku80, mediators of DSBs repair. Results: Low dose-rate (LDR) more efficiently induced apoptosis and senescence in RMS while high dose-rate (HDR) necrosis in PCa. ThisAbstract: Purpose: Radiation therapy (RT), by using ionizing radiation (IR), destroys cancer cells inducing DNA damage. Despite several studies are continuously performed to identify the best curative dose of IR, the role of dose-rate, IR delivered per unit of time, on tumor control is still largely unknown. Materials and methods: Rhabdomyosarcoma (RMS) and prostate cancer (PCa) cell lines were irradiated with 2 or 10 Gy delivered at dose-rates of 1.5, 2.5, 5.5 and 10.1 Gy/min. Cell-survival rate and cell cycle distribution were evaluated by clonogenic assays and flow cytometry, respectively. The production of reactive oxygen species (ROS) was detected by cytometry. Quantitative polymerase chain reaction assessed the expression of anti-oxidant-related factors including NRF2, SODs, CAT and GPx4 and miRNAs (miR-22, -126, -210, -375, -146a, -34a). Annexin V and caspase-8, -9 and -3 activity were assessed to characterize cell death. Senescence was determined by assessing β-galactosidase (SA-β-gal) activity. Immunoblotting was performed to assess the expression/activation of: i) phosphorylated H2AX (γ-H2AX), markers of DNA double strand breaks (DSBs); ii) p19 Kip1/Cip1, p21 Waf1/Cip1 and p27 Kip1/Cip1, senescence-related-markers; iii) p62, LC3-I and LC3-II, regulators of autophagy; iv) ATM, RAD51, DNA-PKcs, Ku70 and Ku80, mediators of DSBs repair. Results: Low dose-rate (LDR) more efficiently induced apoptosis and senescence in RMS while high dose-rate (HDR) necrosis in PCa. This paralleled with a lower ability of LDR-RMS and HDR-PCa irradiated cells to activate DSBs repair. Modulating the dose rate did not differently affect the anti-oxidant ability of cancer cells. Conclusion: The present results indicate that a stronger cytotoxic effect was induced by modulating the dose-rate in a cancer cell-dependent manner, this suggesting that choose the dose-rate based on the individual patient's tumor characteristics could be strategic for effective RT exposures. … (more)
- Is Part Of:
- International journal of radiation biology. Volume 96:Number 6(2020)
- Journal:
- International journal of radiation biology
- Issue:
- Volume 96:Number 6(2020)
- Issue Display:
- Volume 96, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 96
- Issue:
- 6
- Issue Sort Value:
- 2020-0096-0006-0000
- Page Start:
- 823
- Page End:
- 835
- Publication Date:
- 2020-06-02
- Subjects:
- Rhabdomyosarcoma -- prostate cancer -- radiotherapy -- dose rate -- reactive oxygen species -- double-strand DNA breaks
Radiation -- Physiological effect -- Periodicals
Radiobiology -- Periodicals
571.45 - Journal URLs:
- http://www.tandfonline.com/loi/irab20 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/09553002.2020.1739774 ↗
- Languages:
- English
- ISSNs:
- 0955-3002
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.517900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 13592.xml